Fulgent Genetics (MEX:FLGT) EV-to-Revenue : 1.04 (As of Jun. 02, 2025)

View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Fulgent Genetics's enterprise value is MXN6,064 Mil. Fulgent Genetics's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was MXN5,806 Mil. Therefore, Fulgent Genetics's EV-to-Revenue for today is 1.04.

The historical rank and industry rank for Fulgent Genetics's EV-to-Revenue or its related term are showing as below:

MEX:FLGT' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.46 Med: 2.29 Max: 24.73
Current: 1.07

During the past 11 years, the highest EV-to-Revenue of Fulgent Genetics was 24.73. The lowest was 0.46. And the median was 2.29.

MEX:FLGT's EV-to-Revenue is ranked better than
83.73% of 209 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.78 vs MEX:FLGT: 1.07

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-02), Fulgent Genetics's stock price is MXN330.00. Fulgent Genetics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was MXN190.27. Therefore, Fulgent Genetics's PS Ratio for today is 1.73.

Fulgent Genetics EV-to-Revenue Historical Data

The historical data trend for Fulgent Genetics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics EV-to-Revenue Chart

Fulgent Genetics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-Revenue

Get a 7-Day Free Trial

2.81

2.63

0.63

1.54

1.11

Fulgent Genetics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-Revenue	Get a 7-Day Free Trial															1.22	1.00	1.64	1.11	0.69

Competitive Comparison of Fulgent Genetics's EV-to-Revenue

For the Diagnostics & Research subindustry, Fulgent Genetics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fulgent Genetics's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's EV-to-Revenue falls into.

Save Embed

;

Save Embed

;

Fulgent Genetics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Fulgent Genetics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	6064.232	/	5806.298
	=	1.04

Fulgent Genetics's current Enterprise Value is MXN6,064 Mil.
Fulgent Genetics's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN5,806 Mil.

Fulgent Genetics (MEX:FLGT) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Fulgent Genetics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	330.00	/	190.273
	=	1.73

Fulgent Genetics's share price for today is MXN330.00.
Fulgent Genetics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN190.27.

Fulgent Genetics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4399 Santa Anita Avenue, El Monte, CA, USA, 91731

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.